CJC-1295 with DAC | Extended Half-Life GHRH | 2mg – 5mg | >99% Purity

CJC-1295 with DAC functions as a potent, long-acting analog of endogenous Growth Hormone Releasing Hormone (GHRH). It binds directly to the GHRH receptors on the somatotroph cells in the anterior pituitary gland, signaling them to synthesize and release growth hormone (GH).

The DAC Revolution: Standard CJC-1295 (Modified GRF 1-29) has a extremely short half-life (less than 30 minutes) because it is quickly broken down by blood enzymes. The DAC (Drug Affinity Complex) modification changes everything. When injected, the peptide covalently binds to a serum albumin molecule in the bloodstream. Because albumin is a very stable protein with a multi-day life in circulation, the attached CJC-1295 is “carried” and protected, extending its functional half-life to **6-8 days**.

“GH Bleed” explained: Because the molecule is always present stimulating the pituitary, it changes the way GH is released. Endogenous GH is released in sharp, rare pulses. CJC-1295 with DAC creates a constant, baseline secretion—a continuous “flow” or “leak” of GH into the system (this effect is sometimes called **”GH Bleed”** in research communities). This constant supply of GH commands the liver to consistently and maximized production of **IGF-1**, driving systemic structure repair, growth, and metabolic optimization without the hormone crashes associated with short-acting peptides.